Founded in 2013, Yourgene Health has evolved from a UK-based non-invasive prenatal testing (NIPT) company into an international molecular diagnostics group, offering a wide range of over 100 technologies and services designed to support genomic medicine. Yourgene Health’s vision is to be a trusted leader in molecular diagnostics, driven by technical expertise, innovation, and global partnerships, with a strong commitment to advancing scientific innovations that improve human health.
Yourgene Health provides an extensive range of NIPT and next-generation sequencing (NGS) workflows, tailored for laboratories, along with clinical prenatal screening services. Their IONA® test was the first in vitro diagnostic (IVD) product on the market in 2015, revolutionising NIPT screening.
Building on their expertise in cell-free DNA, Yourgene Health developed the next-generation Ranger® Technology, which employs machine vision for superior precision. This platform supports a wide array of clinical and research applications, including NIPT, liquid biopsy, oncology, and gene synthesis.
Additionally, Yourgene Health offers a range of screening products focused on reproductive health and precision medicine, such as cystic fibrosis assays and DPYD genotyping, to help prevent chemotoxicity.